Literature DB >> 3722636

Biphasic and protracted anaphylaxis.

B J Stark, T J Sullivan.   

Abstract

We performed a prospective study of anaphylaxis in 25 consecutive patients. Three distinct clinical patterns were observed: uniphasic, biphasic, and protracted anaphylaxis. Thirteen patients (52%) experienced a single episode. Biphasic anaphylaxis occurred in five patients (20%), two episodes of hypotension or laryngeal edema separated by asymptomatic intervals of 1 to 8 hours. Initial therapy included large doses of glucocorticoids in three of the five patients. Seven patients (28%) suffered hypotension, lower respiratory obstruction, or laryngeal obstruction that persisted 5 to 32 hours despite vigorous therapy that included systemic glucocorticoids. Recurrent or prolonged reactions were 2.8-fold more likely if the onset was 30 or more minutes after exposure to the stimulus or if the offending agent had been administered by mouth (p less than 0.03). Fatal reactions occurred in one patient who was taking propranolol and in one who was adrenal insufficient. The results of this study demonstrate that biphasic and protracted anaphylaxis are common, despite glucocorticoid therapy. Potentially life-endangering recurrences occurred in five (28%) of the 18 patients who responded to initial therapy. These observations indicate that patients should be followed carefully after apparent remission of anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722636     DOI: 10.1016/0091-6749(86)90117-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  51 in total

Review 1.  Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology.

Authors:  J Ring; H Behrendt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Diagnosis and management of anaphylaxis.

Authors:  Anne K Ellis; James H Day
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

3.  Treating anaphylaxis with sympathomimetic drugs.

Authors:  M Fisher
Journal:  BMJ       Date:  1992-11-07

4.  [Not Available].

Authors:  A Cheng
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

Review 5.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 6.  8 management of allergy, rashes, and itching.

Authors:  M Langran; C Laird
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

7.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 8.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

9.  Allergies in children.

Authors:  Z Chad
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

10.  Fatal asthma or anaphylaxis?

Authors:  J Rainbow; G J Browne
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.